TABLE 2.
Characteristics of included studies or consortia of cancer.
| Type of Cancer | Source | Year | Sample size | Population |
|---|---|---|---|---|
| Overall cancer | UKBB | 2018 | 461311 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Bronchus and lung | UKBB | 2018 | 361194 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| ILCCO | 2014 | 27209 | European | |
| Breast | UKBB | 2018 | 462933 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| BCAC | 2017 | 228951 | European | |
| Pancreas | PanScan1 | 2009 | 3,835 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Colon | UKBB | 2018 | 462933 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Rectum | UKBB | 2018 | 463010 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Kidney | UKBB | 2018 | 463010 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Bladder | UKBB | 2018 | 462933 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| Prostate | UKBB | 2018 | 463010 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| PRACTICAL | 2018 | 140254 | European | |
| Ovary | UKBB | 2018 | 463010 | European |
| FinnGen Biobank | 2020 | 96499 | European | |
| OCAC | 2017 | 66450 | European | |
| Uterus/endometrium | UKBB | 2018 | 462933 | European |
| FinnGen Biobank | 2020 | 96499 | European |
Abbreviations: UKBB, United Kingdom, biobank; ILCCO, international lung cancer consortium; BCAC, breast cancer association consortium; PanScan1, Pancreatic Cancer Cohort Consortium GWAS; PRACTICAL, prostate cancer association group to investigate cancer-associated alterations in the genome; OCAC, ovarian cancer association consortium.